Kelly Cleary, JD

Recent Work

• 

  Will the Rebate Rule need Extra Innings?

  The publication of the final rebate rule is an important milestone in this administration’s drug pricing journey. However, many challenges remain.

  By John O’Brien, PharmD, MPH, Kelly Cleary, JD and John Brooks, JD, MBA

  Categorized in Evidence Base
• 

  Are We Gearing Up for a Drug Rebate Rule Instant Replay?

  The so-called “rebate rule” was reported dead in 2019. Here’s why that may not be entirely true.

  By John O’Brien, PharmD, MPH and Kelly Cleary, JD

  Categorized in Evidence Base